J Steven McDougal

Summary

Affiliation: Centers for Disease Control and Prevention
Country: USA

Publications

  1. ncbi request reprint Comparison of HIV type 1 incidence observed during longitudinal follow-up with incidence estimated by cross-sectional analysis using the BED capture enzyme immunoassay
    J Steven McDougal
    Division of HIV AIDS Prevention, National Center for HIV AIDS, STD and TB Prevention, Centers for Disease Control and Prevention, Atlanta, Georgia 30333, USA
    AIDS Res Hum Retroviruses 22:945-52. 2006
  2. ncbi request reprint Surveillance for HIV-1 incidence using tests for recent infection in resource-constrained countries
    J Steven McDougal
    National Center for HIV AIDS, STD, TB Prevention, Centers for Disease Control and Prevention, US Public Health Service, Atlanta, GA 30333, USA
    AIDS 19:S25-30. 2005
  3. doi request reprint Determination of mean recency period for estimation of HIV type 1 Incidence with the BED-capture EIA in persons infected with diverse subtypes
    Bharat S Parekh
    Division of Global AIDS Program, Centers for Disease Control and Prevention, Atlanta, Georgia 30333, USA
    AIDS Res Hum Retroviruses 27:265-73. 2011
  4. ncbi request reprint HIV type 1 incidence estimates by detection of recent infection from a cross-sectional sampling of injection drug users in Bangkok: use of the IgG capture BED enzyme immunoassay
    Dale J Hu
    Division of HIV AIDS Prevention and Division of AIDS, STD, TB Laboratory Research, Centers for Disease Control and Prevention, Atlanta, Georgia 30333, USA
    AIDS Res Hum Retroviruses 19:727-30. 2003
  5. pmc Performance characteristics of the immunoglobulin G-capture BED-enzyme immunoassay, an assay to detect recent human immunodeficiency virus type 1 seroconversion
    Trudy Dobbs
    HIV Immunology and Diagnostics Branch, Mailstop D12, Centers for Disease Control and Prevention, 1600 Clifton Rd, Atlanta, GA 30333, USA
    J Clin Microbiol 42:2623-8. 2004
  6. pmc Assessment of BED HIV-1 incidence assay in seroconverter cohorts: effect of individuals with long-term infection and importance of stable incidence
    Janet M McNicholl
    Division of HIV AIDS Prevention, Centers for Disease Control and Prevention, Atlanta, Georgia, United States of America
    PLoS ONE 6:e14748. 2011
  7. ncbi request reprint Quantitative detection of increasing HIV type 1 antibodies after seroconversion: a simple assay for detecting recent HIV infection and estimating incidence
    Bharat S Parekh
    Division of AIDS, STD, TB Laboratory Research, and Division of HIV AIDS Prevention, Centers for Disease Control and Prevention, Atlanta, Georgia 30333, USA
    AIDS Res Hum Retroviruses 18:295-307. 2002
  8. doi request reprint Evaluation of an alternative HIV diagnostic algorithm using specimens from seroconversion panels and persons with established HIV infections
    Silvina Masciotra
    Division of HIV AIDS Prevention, National Center for HIV AIDS, Hepatitis, STD, and TB Prevention, Atlanta, GA 30333, USA
    J Clin Virol 52:S17-22. 2011
  9. ncbi request reprint Application of laboratory methods for estimation of HIV-1 incidence
    Bharat S Parekh
    HIV Immunology and Diagnostics Branch, Division of HIV AIDS Prevention, National Center for HIV, STD and TB Prevention, Centers for Disease Control and Prevention, Mailstop D 12, 1600 Clifton Road, Atlanta, GA 30333, USA
    Indian J Med Res 121:510-8. 2005
  10. ncbi request reprint Human immunodeficiency virus (HIV) seropositivity among uninfected HIV vaccine recipients
    Marta Louise Ackers
    HIV Vaccine Section, Epidemiology Branch, Division of HIV AIDS Prevention Surveillance and Epidemiology, National Center for HIV, STD, and TB Prevention, Centers for Disease Control and Prevention, Atlanta, Georgia 30333, USA
    J Infect Dis 187:879-86. 2003

Collaborators

Detail Information

Publications13

  1. ncbi request reprint Comparison of HIV type 1 incidence observed during longitudinal follow-up with incidence estimated by cross-sectional analysis using the BED capture enzyme immunoassay
    J Steven McDougal
    Division of HIV AIDS Prevention, National Center for HIV AIDS, STD and TB Prevention, Centers for Disease Control and Prevention, Atlanta, Georgia 30333, USA
    AIDS Res Hum Retroviruses 22:945-52. 2006
    ..Cross-sectional HIV incidence estimation circumvents many of the drawbacks associated with longitudinal cohort studies, but there are test-specific limitations that should be considered in the design of population surveys...
  2. ncbi request reprint Surveillance for HIV-1 incidence using tests for recent infection in resource-constrained countries
    J Steven McDougal
    National Center for HIV AIDS, STD, TB Prevention, Centers for Disease Control and Prevention, US Public Health Service, Atlanta, GA 30333, USA
    AIDS 19:S25-30. 2005
    ....
  3. doi request reprint Determination of mean recency period for estimation of HIV type 1 Incidence with the BED-capture EIA in persons infected with diverse subtypes
    Bharat S Parekh
    Division of Global AIDS Program, Centers for Disease Control and Prevention, Atlanta, Georgia 30333, USA
    AIDS Res Hum Retroviruses 27:265-73. 2011
    ..The determination of ω with more data and new methodology suggests that ω of the BED-CEIA varies between different subtypes and/or populations. These estimates for ω may affect incidence estimates in various studies...
  4. ncbi request reprint HIV type 1 incidence estimates by detection of recent infection from a cross-sectional sampling of injection drug users in Bangkok: use of the IgG capture BED enzyme immunoassay
    Dale J Hu
    Division of HIV AIDS Prevention and Division of AIDS, STD, TB Laboratory Research, Centers for Disease Control and Prevention, Atlanta, Georgia 30333, USA
    AIDS Res Hum Retroviruses 19:727-30. 2003
    ....
  5. pmc Performance characteristics of the immunoglobulin G-capture BED-enzyme immunoassay, an assay to detect recent human immunodeficiency virus type 1 seroconversion
    Trudy Dobbs
    HIV Immunology and Diagnostics Branch, Mailstop D12, Centers for Disease Control and Prevention, 1600 Clifton Rd, Atlanta, GA 30333, USA
    J Clin Microbiol 42:2623-8. 2004
    ..This information provides baseline data for the successful transfer of BED-CEIA to other laboratories and the use of BED-CEIA for the detection of recent HIV seroconversion and the calculation of incidence estimates worldwide...
  6. pmc Assessment of BED HIV-1 incidence assay in seroconverter cohorts: effect of individuals with long-term infection and importance of stable incidence
    Janet M McNicholl
    Division of HIV AIDS Prevention, Centers for Disease Control and Prevention, Atlanta, Georgia, United States of America
    PLoS ONE 6:e14748. 2011
    ..We sought to assess its performance in three longitudinal cohorts from Thailand where HIV-1 CRF01_AE and subtype B' dominate the epidemic...
  7. ncbi request reprint Quantitative detection of increasing HIV type 1 antibodies after seroconversion: a simple assay for detecting recent HIV infection and estimating incidence
    Bharat S Parekh
    Division of AIDS, STD, TB Laboratory Research, and Division of HIV AIDS Prevention, Centers for Disease Control and Prevention, Atlanta, Georgia 30333, USA
    AIDS Res Hum Retroviruses 18:295-307. 2002
    ..This assay should be useful for detecting recent HIV-1 infection and for estimating incidence among diverse HIV-1 subtypes worldwide...
  8. doi request reprint Evaluation of an alternative HIV diagnostic algorithm using specimens from seroconversion panels and persons with established HIV infections
    Silvina Masciotra
    Division of HIV AIDS Prevention, National Center for HIV AIDS, Hepatitis, STD, and TB Prevention, Atlanta, GA 30333, USA
    J Clin Virol 52:S17-22. 2011
    ..Concordant positive results indicate HIV-positive specimens and discordant results are resolved by nucleic acid amplification testing (NAAT)...
  9. ncbi request reprint Application of laboratory methods for estimation of HIV-1 incidence
    Bharat S Parekh
    HIV Immunology and Diagnostics Branch, Division of HIV AIDS Prevention, National Center for HIV, STD and TB Prevention, Centers for Disease Control and Prevention, Mailstop D 12, 1600 Clifton Road, Atlanta, GA 30333, USA
    Indian J Med Res 121:510-8. 2005
    ....
  10. ncbi request reprint Human immunodeficiency virus (HIV) seropositivity among uninfected HIV vaccine recipients
    Marta Louise Ackers
    HIV Vaccine Section, Epidemiology Branch, Division of HIV AIDS Prevention Surveillance and Epidemiology, National Center for HIV, STD, and TB Prevention, Centers for Disease Control and Prevention, Atlanta, Georgia 30333, USA
    J Infect Dis 187:879-86. 2003
    ..The potential for vaccine recipients being misclassified as HIV infected increased with vaccine complexity...
  11. ncbi request reprint A critical evaluation of enzyme immunoassay kits for detection of antinuclear autoantibodies of defined specificities. III. Comparative performance characteristics of academic and manufacturers' laboratories
    Marvin J Fritzler
    Standardization Committee in Rheumatic and Related Disorders, International Union of Immunological Societies, Atlanta, Georgia, USA
    J Rheumatol 30:2374-81. 2003
    ..To analyze the performance of different commercial enzyme immunoassay (EIA) kits for measuring antinuclear antibodies (ANA) specific for dsDNA, SSB/La, Sm, and Scl-70...
  12. ncbi request reprint Guidelines for performing single-platform absolute CD4+ T-cell determinations with CD45 gating for persons infected with human immunodeficiency virus. Centers for Disease Control and Prevention
    Francis F Mandy
    Bureau of HIV AIDS, STD and TB, Population and Public Health Branch, Health Canada, Ottawa, Ontario, Canada
    MMWR Recomm Rep 52:1-13. 2003
    ..The new recommendations address concerns specific to the implementation of SPT as well as other general topics such as laboratory safety and specimen handling...
  13. ncbi request reprint A critical evaluation of enzyme immunoassay kits for detection of antinuclear autoantibodies of defined specificities. II. Potential for quantitation of antibody content
    Eng M Tan
    Autoantibody Standardization Committee in Rheumatic and Related Disorders of the International Union of Immunological Societies, The World Health Organization, The Arthritis Foundation, and Centers for Disease Control and Prevention
    J Rheumatol 29:68-74. 2002
    ..To analyze the performance of different commercial enzyme immunoassay (EIA) kits for measuring antibody levels of antinuclear antibodies (ANA) specific for double stranded (ds) DNA, SSB/La, Sm, and Scl-70...